SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001085146-21-000926
Filing Date
2021-02-16
Accepted
2021-02-16 14:21:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP kptia2_21621.htm SC 13G/A 53640
  Complete submission text file 0001085146-21-000926.txt   55184
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87705 | Film No.: 21636228
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

IRS No.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A